Ken Griffin acquired 3.47 Million Ventyx Biosciences shares worth $120 Million. That's 0.15% of their equity portfolio (151st largest holding). The investor owns 5.96% of the outstanding Ventyx Biosciences stock. Ken Griffin started to build up the position in Ventyx Biosciences in Q4 2021 and continued to invest until Q1 2022. Since then they sold 441 Thousand shares. The stake costed the investor $65.7 Million, netting the investor a gain of 83% so far.